The Allen Institute for Immunology, a division of the Seattle-based Allen Institute, is teaming with Seattle Children’s Research Institute to… Read More
Seattle startup Dopl Technologies has developed a telerobotic ultrasound system intended to bring specialist care to patients in rural areas.… Read More
Boston-based biotech company Vertex Pharmaceuticals agreed to acquire Seattle-based Alpine Immune Sciences for $65 per share, totaling about $4.9 billion… Read More
ProfoundBio, a Seattle-based biotech firm developing drugs to treat ovarian and endometrial cancers, will be acquired by publicly traded Danish… Read More
The news: Modulus Therapeutics, a Seattle-based cellular therapy company spun out of the Allen Institute of Artificial Intelligence (AI2) Incubator,… Read More
Researchers opened the doors Monday to the new Seattle Hub for Synthetic Biology, a collaboration between the Allen Institute, the Chan Zuckerberg… Read More
Healionics, a Seattle-based medical technology company, raised $5.5 million in new financing aimed at helping the company complete an ongoing… Read More
Biotech giant AstraZeneca has completed its $1.1 billion acquisition of Icosavax, a Seattle-based spinout from the University of Washington’s Institute for… Read More
ProfoundBio raised $112 million to support development of its pipeline of antibody-drug conjugates (ADCs), agents that recognize a molecular target via… Read More
Editor’s note: William Canestaro is managing director at Seattle venture capital firm WRF Capital and leads the biotechnology investment team. … Read More
Prenuvo, the celebrity-endorsed company offering $2,500 full-body MRI scans designed to detect cancer and other diseases early, is planning to… Read More
Seattle-based Icosavax, a spin-out from the University of Washington’s Institute for Protein Design, will be acquired by biotech giant AstraZeneca for… Read More
Don't miss a headline!
Sign up for GeekWire's newsletters today.
Thanks for subscribing!
Check your inbox to confirm your subscription.
